Literature DB >> 380186

Animal models of human systemic lupus erythematosus.

D P Huston, A D Steinberg.   

Abstract

Systemic lupus erythematosus (SLE) is a human autoimmune disease of unknown etiology. Clinical, serologic, immunologic, and pathologic findings are highly variable in different patients and at different times in the same patient. Murine and canine animal models of SLE have been found with clinicopathologic abnormalities resembling those observed in humans. Each animal model has unique characteristics; taken together they reflect the spectrum of disease in human SLE.Investigations in the animals have suggested that genetic, hormonal, immunologic, viral, and other environmental factors contribute to and modify the expression of disease. Where analogous studies are available for humans, the same factors have been found to modify disease expression in a similar fashion. Together, these studies have helped to clarify the multifactorial basis for SLE.The best characterized abnormalities are immunologic. These include excessive B cell function with the formation of large amounts of autoantibodies, and T cell abnormalities which include defects in T cell regulatory function as well as certain T cell effector functions.The animal models of SLE also serve as convenient test subjects for newer therapeutic modalities. It is hoped that further study of the animal models will provide a more rational approach to therapeutic modulation of disease in humans with SLE.

Entities:  

Mesh:

Year:  1979        PMID: 380186      PMCID: PMC2595466     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  100 in total

1.  Selective loss of suppressor cell function in New Zealand mice induced by NTA.

Authors:  L W Klassen; R S Krakauer; A D Steinberg
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  Prevention of autoimmunity in experimental lupus erythematosus by soluble immune response suppressor.

Authors:  R S Krakauer; W Strober; D L Rippeon; T A Waldmann
Journal:  Science       Date:  1977-04-01       Impact factor: 47.728

Review 3.  Cellular events associated with the immunogenesis of anti-erythrocyte autoantibody responses of NZB mice.

Authors:  D H Deheer; T S Edginton
Journal:  Transplant Rev       Date:  1976

4.  Ribavirin: efficacy in the treatment of murine autoimmune disease.

Authors:  L W Klassen; D R Budman; G W Williams; A D Steinberg; N L Gerber
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

5.  A new class of murine leukemia virus associated with development of spontaneous lymphomas.

Authors:  J W Hartley; N K Wolford; L J Old; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice.

Authors:  J B Smith; R D Pasternak
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

7.  Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

8.  Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease.

Authors:  A D Steinberg; L W Klassen; D R Budman; G W Williams
Journal:  Arthritis Rheum       Date:  1979-02
View more
  7 in total

1.  Influence of a diet rich in eicosapentaenoic acid on the development of rat paw oedema and on the formation of prostaglandins I2 and E2.

Authors:  W Sametz; H Juan
Journal:  Agents Actions       Date:  1985-12

2.  Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.

Authors:  F Hirata; R del Carmine; C A Nelson; J Axelrod; E Schiffmann; A Warabi; A L De Blas; M Nirenberg; V Manganiello; M Vaughan; S Kumagai; I Green; J L Decker; A D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

3.  Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.

Authors:  D Sergiescu; I Cerutti; A Kahan; D Piatier; E Efthymiou
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

4.  Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.

Authors:  J D Prickett; D R Robinson; A D Steinberg
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

5.  CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms.

Authors:  Èlia Ripoll; Ana Merino; Immaculada Herrero-Fresneda; Josep M Aran; Montse Goma; Nuria Bolaños; Laura de Ramon; Oriol Bestard; Josep M Cruzado; Josep M Grinyó; Juan Torras
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

6.  T cell abnormalities in NZB mice occur independently of autoantibody production.

Authors:  J D Taurog; E S Raveche; P A Smathers; L H Glimcher; D P Huston; C T Hansen; A D Steinberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

Review 7.  Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology.

Authors:  Tim D Hewitson; Stephen G Holt; Edward R Smith
Journal:  Front Immunol       Date:  2015-09-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.